Trial Outcomes & Findings for Treatment for Post-Stroke Depression (NCT NCT00029172)

NCT ID: NCT00029172

Last Updated: 2023-02-16

Results Overview

Depression remission was defined as HAM-D less than 8 or HAM-D decreased by 50%. The Hamilton Rating Scale for Depression is measured on a scale from no depression - major depression, 0-52 units on a scale.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

188 participants

Primary outcome timeframe

Twelve week

Results posted on

2023-02-16

Participant Flow

Subjects were recruited from 4 Indianapolis based hospitals. Depression enrollment and screening occurred between 1 and 2 months post stroke.

Participant milestones

Participant milestones
Measure
Case Management
Overall Study
STARTED
188
Overall Study
COMPLETED
182
Overall Study
NOT COMPLETED
6

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Treatment for Post-Stroke Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Case Management
n=182 Participants
Age, Continuous
61 years
STANDARD_DEVIATION 3 • n=99 Participants
Sex: Female, Male
Female
99 Participants
n=99 Participants
Sex: Female, Male
Male
83 Participants
n=99 Participants
Region of Enrollment
United States
182 participants
n=99 Participants

PRIMARY outcome

Timeframe: Twelve week

Depression remission was defined as HAM-D less than 8 or HAM-D decreased by 50%. The Hamilton Rating Scale for Depression is measured on a scale from no depression - major depression, 0-52 units on a scale.

Outcome measures

Outcome measures
Measure
Case Management
n=182 Participants
Twelve Week Depression Outcomes
10.6 HAM-D depression score
Standard Deviation 6.9

Adverse Events

Case Management

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Linda Williams

Roudebush VAMC Center of Excellence

Phone: 317-988-3337

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place